FDA approves expanded use of Lymphoseek® for lymphatic mapping in solid tumors

[News]

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, has announced that the U.S.

More... (http://www.medicalnewstoday.com/releases/284524.php)